Br J Haematol 2004,125(6):749–755.PubMed 160. Eisenbarth GS: Update in type 1 diabetes. J Clin Endocrinol Metab 2007,92(7):2403–2407.PubMed 161. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R: Diabetic retinopathy. Diabetes Care 1998,21(1):143–156.PubMed 162. Sima AA, Zhang W, Grunberger G: Type 1 diabetic neuropathy and C-peptide. Exp Diabesity Res 2004,5(1):65–77.PubMed 163. Ingberg
CM, Palmer M, Schvarcz E, Aman J: Prevalence of urinary tract symptoms in long-standing type 1 diabetes mellitus. Diabetes Metab 1998,24(4):351–354.PubMed 164. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simoes BP, et al.: C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009,301(15):1573–1579.PubMed 165. Snarski E, Torosian T, Paluszewska PARP inhibitor M, Urbanowska E, Milczarczyk A, Jedynasty K, Franek E, Jedrzejczak WW: Alleviation of exogenous insulin requirement in type
1 diabetes mellitus after immunoablation selleck and transplantation of autologous hematopoietic stem cells. Pol Arch Med Wewn 2009,119(6):422–426.PubMed 166. Trivedi HL, Vanikar AV, Thakker U, Firoze A, Dave SD, Patel CN, Patel JV, Bhargava AB, Shankar V: Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplant Proc 2008,40(4):1135–1139.PubMed 167. Wijesekera LC, Leigh PN: Amyotrophic lateral sclerosis. Orphanet http://www.selleck.co.jp/products/Docetaxel(Taxotere).html J Rare Dis 2009, 4:3.PubMed 168. Janson CG, Ramesh TM, During MJ, Leone P, Heywood J: Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. J Hematother Stem Cell Res 2001,10(6):913–915.PubMed 169. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, Testa L, Stecco A, Tarletti R, Miglioretti M, et al.: Mesenchymal stem cell transplantation
in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol 2010,223(1):229–37.PubMed 170. Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, Pastore I, Marasso R, Madon E: Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003,4(3):158–161.PubMed 171. Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, Caro E, Gutierrez-Jimenez E, Segura JJ: Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 2009,11(1):26–34.PubMed 172. Papadeas ST, Maragakis NJ: Advances in stem cell research for Amyotrophic Lateral Sclerosis. Curr Opin Biotechnol 2009,20(5):545–551.PubMed 173. Astradsson A, Cooper O, Vinuela A, Isacson O: Recent advances in cell-based therapy for Parkinson disease. Neurosurg Focus 2008,24(3–4):E6.PubMed 174. Weintraub D, Comella CL, Horn S: selleckchem Parkinson’s disease–Part 2: Treatment of motor symptoms.